TVGN Tevogen Bio Holdings Inc.

Price (delayed)

$9.86

Market cap

$41.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.69

Enterprise value

$50.07M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 7

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN ...

Highlights
The net income is up by 31% year-on-year and by 18% since the previous quarter
The EPS has grown by 31% YoY and by 17% from the previous quarter
The company's quick ratio has shrunk by 50% YoY but it rose by 20% QoQ
The debt has soared by 96% YoY and by 26% from the previous quarter
Tevogen Bio Holdings's equity has decreased by 27% YoY and by 20% QoQ

Key stats

What are the main financial stats of TVGN

TVGN stock price

How has the Tevogen Bio Holdings stock price performed over time
Intraday
8.83%
1 week
22.64%
1 month
33.06%
1 year
-84.83%
YTD
-40.46%
QTD
118.14%

Financial performance

How have Tevogen Bio Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$21.19M
Net income
-$21.94M
Gross margin
N/A
Net margin
N/A
The operating income has increased by 38% year-on-year and by 19% since the previous quarter
The net income is up by 31% year-on-year and by 18% since the previous quarter

Price vs fundamentals

How does TVGN's price correlate with its fundamentals

Growth

What is Tevogen Bio Holdings's growth rate over time

Valuation

What is Tevogen Bio Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 31% YoY and by 17% from the previous quarter
Tevogen Bio Holdings's equity has decreased by 27% YoY and by 20% QoQ

Efficiency

How efficient is Tevogen Bio Holdings business performance
The company's return on invested capital has surged by 56% QoQ
The return on assets has grown by 42% year-on-year and by 22% since the previous quarter

Dividends

What is TVGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TVGN.

Financial health

How did Tevogen Bio Holdings financials performed over time
TVGN's total assets is 67% lower than its total liabilities
The company's quick ratio has shrunk by 50% YoY but it rose by 20% QoQ
TVGN's current ratio is up by 32% since the previous quarter but it is down by 17% year-on-year
The debt is 196% more than the equity
The debt has soared by 96% YoY and by 26% from the previous quarter
The debt to equity has shrunk by 55% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.